AR098771A1 - Un dispositivo para la administración transdérmica de rotigotina - Google Patents

Un dispositivo para la administración transdérmica de rotigotina

Info

Publication number
AR098771A1
AR098771A1 ARP140104682A ARP140104682A AR098771A1 AR 098771 A1 AR098771 A1 AR 098771A1 AR P140104682 A ARP140104682 A AR P140104682A AR P140104682 A ARP140104682 A AR P140104682A AR 098771 A1 AR098771 A1 AR 098771A1
Authority
AR
Argentina
Prior art keywords
rotigotine
transdermal administration
styrene
adhesive polymer
rotigotina
Prior art date
Application number
ARP140104682A
Other languages
English (en)
Original Assignee
Amarin Tech S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Tech S A filed Critical Amarin Tech S A
Priority to ARP140104682A priority Critical patent/AR098771A1/es
Priority to PCT/EP2015/079770 priority patent/WO2016096840A1/en
Priority to EP15820454.5A priority patent/EP3233125B1/en
Priority to US15/535,940 priority patent/US20170340578A1/en
Publication of AR098771A1 publication Critical patent/AR098771A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un sistema de administración transdérmica (SAT) para la administración transdérmica de rotigotina, que comprende una capa de matriz adhesiva, una lámina de soporte y una lámina de despegue, donde la matriz adhesiva contiene a la rotigotina, un polímero adhesivo y un copolímero de polietilenglicol, polivinilcaprolactamo y polivinilacetato. De forma preferencial, el polímero adhesivo en bloque es del tipo estireno-isopreno-estireno (SIS). Reivindicación 3: Un dispositivo para la administración transdérmica de rotigotina de acuerdo con la reivindicación anterior, caracterizado porque dicho polímero adhesivo en bloque del tipo estireno-isopreno-estireno se encuentra en una concentración de entre alrededor de 50% y alrededor de 80%. Reivindicación 8: Un dispositivo para la administración transdérmica de rotigotina de acuerdo con una cualquiera de las reivindicaciones anteriores, caracterizado porque la rotigotina se encuentra en una concentración de entre alrededor de 5% y alrededor de 30%.
ARP140104682A 2014-12-16 2014-12-16 Un dispositivo para la administración transdérmica de rotigotina AR098771A1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ARP140104682A AR098771A1 (es) 2014-12-16 2014-12-16 Un dispositivo para la administración transdérmica de rotigotina
PCT/EP2015/079770 WO2016096840A1 (en) 2014-12-16 2015-12-15 A device for the transdermal delivery of rotigotine
EP15820454.5A EP3233125B1 (en) 2014-12-16 2015-12-15 A device for the transdermal delivery of rotigotine
US15/535,940 US20170340578A1 (en) 2014-12-16 2015-12-15 Device for the transdermal delivery of rotigotine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP140104682A AR098771A1 (es) 2014-12-16 2014-12-16 Un dispositivo para la administración transdérmica de rotigotina

Publications (1)

Publication Number Publication Date
AR098771A1 true AR098771A1 (es) 2016-06-15

Family

ID=56125975

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140104682A AR098771A1 (es) 2014-12-16 2014-12-16 Un dispositivo para la administración transdérmica de rotigotina

Country Status (4)

Country Link
US (1) US20170340578A1 (es)
EP (1) EP3233125B1 (es)
AR (1) AR098771A1 (es)
WO (1) WO2016096840A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210005623A (ko) * 2018-04-25 2021-01-14 신케이 테라퓨틱스 엘엘씨 테트라베나진 경피 전달 장치
JP7173415B2 (ja) * 2020-08-19 2022-11-16 東洋インキＳｃホールディングス株式会社 貼付剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2640389T3 (en) * 2010-11-17 2015-03-09 Hexal Ag Transdermal therapeutic system comprising buprenorphine
WO2013075822A1 (en) * 2011-11-22 2013-05-30 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermal therapeutic system (tts) with rotigotine
KR20140103168A (ko) * 2011-12-16 2014-08-25 알러간, 인코포레이티드 폴리비닐 카프라락탐-폴리비닐 아세테이트-폴리에틸렌 글리콜 그라프트 코폴리머를 포함하는 안과 조성물
TW201431570A (zh) * 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
JP2016135744A (ja) * 2013-05-08 2016-07-28 株式会社 ケイ・エム トランスダーム 貼付剤

Also Published As

Publication number Publication date
EP3233125B1 (en) 2019-04-03
EP3233125A1 (en) 2017-10-25
US20170340578A1 (en) 2017-11-30
WO2016096840A1 (en) 2016-06-23

Similar Documents

Publication Publication Date Title
CL2018003754A1 (es) Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo.
CL2015003377A1 (es) Sistema de liberación transdérmico.
AR105205A1 (es) Sustrato adhesivo desechable adaptado para ser dispuesto sobre un dispositivo médico
CL2015001852A1 (es) Películas de ésteres de poli alfa-1, 3-glucano y metodo para su preparación
CR20140487A (es) Peliculas de capas multiples capaces de liberar ingredientes activos por un periodo limitado de tiempo
PH12015502280A1 (en) Transdermal delivery system comprising donepezil or its salt
AR095258A1 (es) Composiciones transdérmicas de metilfenidato con adhesivos a base de goma
CO6561814A2 (es) Tira dental para la administracion de tratamiento por la via oral
CL2017000394A1 (es) Composición que contiene cineol para la administración nasal
AR094289A1 (es) Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol
AR094290A1 (es) Composiciones y metodos para la administracion transdermica de agentes antiinflamatorios no esteroideos
PE20160534A1 (es) Sistema de administracion intrauterina
AR107832A1 (es) Película superficial para impresión y laminados sensibles a la presión que la incluyen
AU2018345723A8 (en) Dextromethorphan transdermal delivery device
AR089765A1 (es) Un sistema para el suministro de un farmaco
MX2020003665A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende por lo menos un aditivo.
MX2020003667A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero de silicona.
BR112017023476B8 (pt) Dispositivo de aplicação para distribuir um sistema de regeneração de esmalte para as superfícies dentárias
AR098771A1 (es) Un dispositivo para la administración transdérmica de rotigotina
ECSP16086232A (es) (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
AR114030A1 (es) Triterpenos pentacíclicos en el tratamiento de una patología oral-dental
DOP2016000198A (es) Formulaciones tópicas de heparina
PH12017501563A1 (en) Oligomeric/polymeric silicone fluids for use in transdermal drug delivery systems
MX2015010967A (es) Formulaciones transdermicas de laquinimod.
CL2015003235A1 (es) Aparato y método para determinar una o mas características de un material viscoso

Legal Events

Date Code Title Description
FB Suspension of granting procedure